Comment on "Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss"

Affiliations

Comment

Joshua R Ehrlich et al. Clin Ophthalmol. 2017.

. 2017 Jun 12:11:1119-1120.

doi: 10.2147/OPTH.S140149. eCollection 2017.

¹ Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.

No abstract available

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this communication.

Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss.
Patodia Y, Golesic E, Mao A, Hutnik CM. Patodia Y, et al. Clin Ophthalmol. 2017 Apr 10;11:683-687. doi: 10.2147/OPTH.S128425. eCollection 2017. Clin Ophthalmol. 2017. PMID: 28435219 Free PMC article.

1. Patodia Y, Golesic E, Mao A, Hutnik CML. Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss. Clin Ophthalmol. 2017;11:683–687. - PMC - PubMed
1. Ehrlich JR, Spaeth GL, Carlozzi NE, Lee PP. Patient-centered outcome measures to assess functioning in randomized controlled trials of low-vision rehabilitation: a review. Patient. 2017;10(1):39–49. - PubMed
1. Owsley C, McGwin G, Lee PP, Wasserman N, Searcey K. Characteristics of low-vision rehabilitation services in the United States. Arch Ophthalmol. 2009;127(5):681–689. - PMC - PubMed
1. Stelmack JA, Szlyk JP, Stelmack TR, et al. Psychometric properties of the Veterans Affairs Low-Vision Visual Functioning Questionnaire. Invest Ophthalmol Vis Sci. 2004;45(11):3919–3928. - PubMed
1. Ehrlich JR, Ojeda LV, Wicker D, et al. Head-mounted display technology for low-vision rehabilitation and vision enhancement. Am J Ophthalmol. 2017;176:26–32. - PMC - PubMed